Clinical Trial Results:
A Phase IIb, 12-week, multicenter, randomized, double-blind, placebo-controlled,
pioglitazone-controlled, parallel-group dose-ranging study in approximately 336 male
and female subjects, aged 18 to 70 years with type 2 diabetes mellitus who are treatment
naïve.
Summary
|
|
EudraCT number |
2006-004694-97 |
Trial protocol |
HU LT LV CZ BG DE |
Global completion date |
14 Feb 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
20 Nov 2016
|
First version publication date |
20 Nov 2016
|
Other versions |
|
Summary report(s) |
gsk-105255-synopsis-redact |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.